Navalign LLC’s AstraZeneca AZN Stock Holding History

Navalign LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$231K	Buy	1,431 +119	+9%	+$19.8K	0.05%	113
2026 Q2	$249K	Hold	1,312	–	–	0.06%	117
2026 Q1	$259K	Sell	1,312 -1	-0.1%	-$193	0.07%	111
2025 Q4	$241K	Hold	1,313	–	–	0.06%	111
2025 Q3	$201K	Buy	+1,313	New	+$199K	0.05%	118
2024 Q4	–	Sell	-1,313	Closed	-$205K	–	117
2024 Q3	$205K	Hold	1,313	–	–	0.06%	118
2024 Q2	$205K	Buy	+1,313	New	+$198K	0.06%	109

Other funds holding AZN

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Navalign LLC's AZN Position: Q3 2026 in Review

Navalign LLC increased its AstraZeneca (AZN) stake by 9.1% in Q3 2026, buying an estimated $19.8K and bringing the position to 1,431 shares worth $231K. The position accounts for 0.05% of the portfolio, ranked #113.

Navalign LLC first reported a position in AZN in Q2 2024 and has held it in 7 quarters since. The position peaked at $259K in Q1 2026. 918 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Navalign LLC held 1,431 shares of AstraZeneca worth $231K as of Q3 2026.
Navalign LLC bought 119 AstraZeneca shares in Q3 2026, an estimated $19.8K.
AstraZeneca made up 0.05% of Navalign LLC's portfolio in Q3 2026, its #113 holding.
Navalign LLC first reported a position in AstraZeneca in Q2 2024 and has held it in 7 quarters since.
Navalign LLC's AstraZeneca position peaked at $259K in Q1 2026.
918 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Navalign LLC's 13F filing for Q3 2026, filed 9 Nov 2026.